Rationale and design of a multi‐center, prospective randomized controlled trial on the effects of sacubitril–valsartan versus enalapril on left ventricular remodeling in ST‐elevation myocardial infarction: The PERI‐STEMI study

BACKGROUND: Angiotensin receptor neprilysin inhibitor (ARNI) sacubitril‐valsartan has been recommended as one of the first‐line therapies in heart failure with reduced ejection fraction. However, whether ARNI could benefit patients with ST‐segment elevation myocardial infarction (STEMI) by improving...

Descripción completa

Detalles Bibliográficos
Autores principales: Diao, Kaiyue, Wang, Duolao, Chen, Zhongxiu, Wu, Xi, Ma, Min, Zhu, Ye, Zhang, Li, Wang, Hua, Wang, Mian, He, Sen, Li, Chen, Deng, Qiao, Yan, Ting, Wu, Tao, Tang, Lu, Huang, Baotao, Sun, Jiayu, He, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2021
Materias:
Clinical Study Design
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715395/
https://www.ncbi.nlm.nih.gov/pubmed/34668596
http://dx.doi.org/10.1002/clc.23744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715395/
https://www.ncbi.nlm.nih.gov/pubmed/34668596
http://dx.doi.org/10.1002/clc.23744

Ejemplares similares